To assess their functional fitness, CD19-CAR-iNKT cells were challenged against SEM (CD19+ ALL cell line), Raji (Burkitt lymphoma cell line) and ALL patient blasts (about 95% blasts in PBMCs) at different ratios for 4 hours and analyzed by flow cytometry and ImageStream. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.